HomeBOT • ASX
add
Botanix Pharmaceuticals Ltd
Previous close
$0.37
Day range
$0.36 - $0.42
Year range
$0.18 - $0.54
Market cap
740.00M AUD
Avg Volume
7.88M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 188.80K | -0.09% |
Operating expense | 15.57M | 532.16% |
Net income | -15.44M | -464.98% |
Net profit margin | -8.18K | -465.47% |
Earnings per share | — | — |
EBITDA | -15.43M | -459.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.44M | 164.49% |
Total assets | 99.45M | 108.57% |
Total liabilities | 6.96M | 203.76% |
Total equity | 92.49M | — |
Shares outstanding | 1.82B | — |
Price to book | 7.30 | — |
Return on assets | -40.19% | — |
Return on capital | -42.81% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.44M | -464.98% |
Cash from operations | -15.28M | -712.75% |
Cash from investing | -426.99K | 94.22% |
Cash from financing | 200.20K | -98.50% |
Net change in cash | -15.44M | -482.88% |
Free cash flow | -4.57M | 45.34% |
About
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Founded
1984
Website
Employees
11
